Why 10x Genomics’ Soaring Q4 Revenue Wasn’t Enough to Impress Investors

If you want evidence that investors are excited about genetic testing stocks, just take a look at 10x Genomics (NASDAQ: TXG). Its shares skyrocketed 86% in 2020 and are up over 30% so far this year. 10x Genomics announced its fourth-quarter and full-year 2020 results after the maRead MoreMarketsMarkets Feed